In this issue:
Should NSTE-ACS patients undergoing PCI be pretreated with P2Y12 receptor antagonists?
Acute cardiovascular events associated with influenza
CIED placement complications in public vs private hospitals in Australia
Add-on bempedoic acid in patients with hypercholesterolaemia
CRP and lipoprotein(a)-associated cardiovascular risk in high-risk vascular disease
Cardiovascular and renal outcomes with empagliflozin in HF patients
Cardiac outcomes with empagliflozin in patients with HFrEF and diabetes
Lowering LDL cholesterol levels in older patients
Time-to-benefit of statins for primary prevention in adults aged 50–75 years
Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve
Please login below to download this issue (PDF)